Product Description
Overall, the global annuloplasty repair device market was valued at $238 million in 2023. This is expected to increase over the forecast period at a CAGR of 2.0% to reach $274 million.
The full report suite on the global market for annuloplasty repair device includes devices used in mitral and tricuspid valve repair. Edwards Lifesciences, Medtronic, and Corcym were the top three market share leaders in the global mechanical heart valve market.
MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2030, and Historical Data to 2020
- Recent Mergers & Acquisitions
- Disease Overviews
- Company Profiles, Product Portfolios, and SWOT for Top Competitors
GLOBAL ANNULOPLASTY REPAIR DEVICE MARKET INSIGHTS
The mitral valve replacement system, initially approved in North America, is set to revolutionize heart surgery on a global scale in the coming years, shifting focus from repairs to replacements. As advanced degradation of valves increases, the preference for replacements over repairs is likely to rise, diminishing growth in the annuloplasty repair device market traditionally focused on the mitral valve. Conversely, investment is steering towards the tricuspid valve segment, where companies like Abbott see potential for growth, drawing on their experience in the mitral valve market to explore opportunities in this niche area.
GLOBAL ANNULOPLASTY REPAIR DEVICE MARKET SHARE INSIGHTS
Edwards Lifesciences leads the annuloplasty repair device market, featuring a comprehensive product lineup that includes Carpentier-Edwards Physio™, Physio II™, and the Carpentier-McCarthy-Adams IMR ETLOGIX Annuloplasty Ring. The company is poised to maintain its market dominance, with strategic focus on expanding markets.
Medtronic, ranked second, offers a diverse array of annuloplasty solutions such as Contour 3D®, CG Future®, and Tri-Ad™ Adams systems. Following its exit from the ventricular assist device sector, Medtronic is set to enhance its market footprint in annuloplasty.
Corcym, holding the third spot in the market, provides innovative devices like Memo 3D Rechord™ and Carbomedics Annuloflo™. With a focused product portfolio, Corcym is anticipated to increase its market share in the upcoming period.
RESEARCH SCOPE SUMMARY
Report Attribute | Details |
---|---|
Regions | North America(Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe(Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East(Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Mongolia, Malaysia, Myanmar, New Zealand, Philippines, Pakistan, Singapore, South Korea, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
Base Year | 2023 |
Forecast | 2024-2030 |
Historical Data | 2020-2023 |
Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |